Trial intelligence / Profile preview

Copaxone for Neuroprotection in Diabetic Retinopathy After PRP

NCT00677664Phase 4Unknown

Sponsor
Federal University of São Paulo
Start
Jul 2006
Primary completion
Jul 2008
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of glatiramer acetate in diabetic retinopathy (DR), sponsored by Federal University of São Paulo. Status: unknown.

02

Drugs

glatiramer acetate
03

Conditions

diabetic retinopathy (DR)

Beyond the preview

Go deeper on NCT00677664.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00677664.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call